EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.4.1.102 | beta-D-galactosyl-1,3-(6-deoxy)-N-acetyl-D-galactosaminyl-benzyl | high concentration | Homo sapiens | |
2.4.1.102 | beta-D-galactosyl-1,3-(6-deoxy)-N-acetyl-D-galactosaminyl-benzyl | high concentration | Mus musculus | |
2.4.1.102 | Cu2+ | - |
Homo sapiens | |
2.4.1.102 | Cu2+ | - |
Mus musculus | |
2.4.1.102 | Cu2+ | - |
Rattus norvegicus | |
2.4.1.102 | Cu2+ | - |
Sus scrofa |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.4.1.102 | additional information | - |
additional information | - |
Homo sapiens | |
2.4.1.102 | additional information | - |
additional information | - |
Sus scrofa | |
2.4.1.102 | 0.6 | - |
beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-p-nitrophenyl | AML cell line | Homo sapiens | |
2.4.1.102 | 0.8 | - |
beta-D-galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl-benzyl | AML cell line | Homo sapiens | |
2.4.1.102 | 1.1 | - |
beta-D-galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl-benzyl | - |
Gallus gallus | |
2.4.1.102 | 1.1 | - |
beta-D-galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl-benzyl | - |
Sus scrofa | |
2.4.1.102 | 1.2 | - |
beta-D-galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl-benzyl | - |
Rattus norvegicus | |
2.4.1.102 | 1.4 | - |
beta-D-galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl-benzyl | - |
Sus scrofa | |
2.4.1.102 | 1.4 | - |
beta-D-galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl-benzyl | colon | Homo sapiens | |
2.4.1.102 | 2 | - |
beta-D-galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl-benzyl | - |
Mus musculus | |
2.4.1.102 | 2 | - |
3-deoxy-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | - |
Mus musculus | |
2.4.1.102 | 2 | - |
beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-o-nitrophenyl | AML cell line | Homo sapiens | |
2.4.1.102 | 3.1 | - |
4-deoxy-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | - |
Mus musculus | |
2.4.1.102 | 3.3 | - |
3-deoxy-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | AML cell line | Homo sapiens | |
2.4.1.102 | 4.2 | - |
4-deoxy-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | - |
Rattus norvegicus | |
2.4.1.102 | 4.3 | - |
3-deoxy-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | - |
Rattus norvegicus | |
2.4.1.102 | 4.5 | - |
3-deoxy-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | colon | Homo sapiens | |
2.4.1.102 | 5 | - |
4-deoxy-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | - |
Sus scrofa | |
2.4.1.102 | 5.5 | - |
3-deoxy-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | - |
Sus scrofa | |
2.4.1.102 | 6.7 | - |
4-deoxy-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | AML cell line | Homo sapiens | |
2.4.1.102 | 10 | - |
beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-phenyl | AML cell line | Homo sapiens | |
2.4.1.102 | 10 | - |
4-deoxy-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | colon | Homo sapiens | |
2.4.1.102 | 12 | - |
beta-D-galactosyl-1,3-(6-deoxy)-N-acetyl-D-galactosaminyl-benzyl | - |
Mus musculus | |
2.4.1.102 | 21 | - |
beta-D-galactosyl-1,3-(6-deoxy)-N-acetyl-D-galactosaminyl-benzyl | colon | Homo sapiens | |
2.4.1.102 | 29 | - |
beta-D-galactosyl-1,3-(6-deoxy)-N-acetyl-D-galactosaminyl-benzyl | AML cells | Homo sapiens | |
2.4.1.102 | 37 | - |
beta-D-galactosyl-1,3-(6-deoxy)-N-acetyl-D-galactosaminyl-benzyl | CML cells | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.4.1.102 | microsome | - |
Gallus gallus | - |
- |
2.4.1.102 | microsome | - |
Homo sapiens | - |
- |
2.4.1.102 | microsome | - |
Rattus norvegicus | - |
- |
2.4.1.102 | microsome | - |
Sus scrofa | - |
- |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
2.4.1.102 | additional information | stimulation by divalent cations | Mus musculus | |
2.4.1.102 | additional information | stimulation by divalent cations | Homo sapiens | |
2.4.1.102 | additional information | stimulation by divalent cations | Rattus norvegicus | |
2.4.1.102 | additional information | stimulation by divalent cations | Sus scrofa |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.1.102 | additional information | Mus musculus | - |
? | - |
? | |
2.4.1.102 | additional information | Rattus norvegicus | - |
? | - |
? | |
2.4.1.102 | additional information | Sus scrofa | - |
? | - |
? | |
2.4.1.102 | additional information | Homo sapiens | enzyme activity is increased in patients with chronic myelogenous leukemia CML or acute myeloid leukemia AML | ? | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-R | Mus musculus | involved in biosynthesis of O-glycans core class 2 | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-R | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-R | Homo sapiens | involved in biosynthesis of O-glycans core class 2 | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-R | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-R | Rattus norvegicus | involved in biosynthesis of O-glycans core class 2 | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-R | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-R | Sus scrofa | involved in biosynthesis of O-glycans core class 2 | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-R | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.1.102 | Gallus gallus | - |
- |
- |
2.4.1.102 | Homo sapiens | - |
- |
- |
2.4.1.102 | Mus musculus | - |
- |
- |
2.4.1.102 | Rattus norvegicus | - |
- |
- |
2.4.1.102 | Sus scrofa | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.4.1.102 | acute myeloid leukemia cell | acute myeloid leukemia blast cell line | Homo sapiens | - |
2.4.1.102 | CML cell | chronic myelogenous leukemia granulocyte cell line | Homo sapiens | - |
2.4.1.102 | colonic mucosa | - |
Rattus norvegicus | - |
2.4.1.102 | gastric mucosa | - |
Sus scrofa | - |
2.4.1.102 | kidney | - |
Mus musculus | - |
2.4.1.102 | oviduct | - |
Gallus gallus | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
2.4.1.102 | additional information | - |
overview: enzyme activities with several substrates | Gallus gallus |
2.4.1.102 | additional information | - |
overview: enzyme activities with several substrates | Mus musculus |
2.4.1.102 | additional information | - |
overview: enzyme activities with several substrates | Homo sapiens |
2.4.1.102 | additional information | - |
overview: enzyme activities with several substrates | Rattus norvegicus |
2.4.1.102 | additional information | - |
overview: enzyme activities with several substrates | Sus scrofa |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.1.102 | additional information | - |
Mus musculus | ? | - |
? | |
2.4.1.102 | additional information | - |
Rattus norvegicus | ? | - |
? | |
2.4.1.102 | additional information | - |
Sus scrofa | ? | - |
? | |
2.4.1.102 | additional information | enzyme activity is increased in patients with chronic myelogenous leukemia CML or acute myeloid leukemia AML | Homo sapiens | ? | - |
? | |
2.4.1.102 | UDP-N-acetyl-alpha-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl-benzyl | - |
Gallus gallus | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D- galactosaminyl-benzyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-alpha-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl-benzyl | - |
Mus musculus | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D- galactosaminyl-benzyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-alpha-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl-benzyl | - |
Homo sapiens | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D- galactosaminyl-benzyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-alpha-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl-benzyl | - |
Rattus norvegicus | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D- galactosaminyl-benzyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-alpha-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-alpha-D-galactosaminyl-benzyl | - |
Sus scrofa | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D- galactosaminyl-benzyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + 3-deoxy-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | - |
Mus musculus | UDP + 3-deoxy-beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-benzyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + 3-deoxy-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | - |
Homo sapiens | UDP + 3-deoxy-beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-benzyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + 3-deoxy-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | - |
Rattus norvegicus | UDP + 3-deoxy-beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-benzyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + 3-deoxy-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | - |
Sus scrofa | UDP + 3-deoxy-beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-benzyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + 4-deoxy-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | - |
Mus musculus | UDP + 4-deoxy-beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-benzyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + 4-deoxy-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | - |
Homo sapiens | UDP + 4-deoxy-beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-benzyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + 4-deoxy-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | - |
Rattus norvegicus | UDP + 4-deoxy-beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-benzyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + 4-deoxy-beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | - |
Sus scrofa | UDP + 4-deoxy-beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-benzyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-(6-deoxy)-N-acetyl-D-galactosaminyl-benzyl | - |
Rattus norvegicus | ? | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-(6-deoxy)-N-acetyl-D-galactosaminyl-benzyl | - |
Sus scrofa | ? | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-(6-deoxy)-N-acetyl-D-galactosaminyl-benzyl | at high concentration inhibitory | Gallus gallus | ? | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-(6-deoxy)-N-acetyl-D-galactosaminyl-benzyl | at high concentration inhibitory | Mus musculus | ? | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-(6-deoxy)-N-acetyl-D-galactosaminyl-benzyl | at high concentration inhibitory | Homo sapiens | ? | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | requirement for the 4- and 6-hydroxyls of N-acetyl-galactosamine and the hydroxyl of galactose in the acceptor substrate | Gallus gallus | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-benzyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | requirement for the 4- and 6-hydroxyls of N-acetyl-galactosamine and the hydroxyl of galactose in the acceptor substrate | Mus musculus | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-benzyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | requirement for the 4- and 6-hydroxyls of N-acetyl-galactosamine and the hydroxyl of galactose in the acceptor substrate | Homo sapiens | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-benzyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | requirement for the 4- and 6-hydroxyls of N-acetyl-galactosamine and the hydroxyl of galactose in the acceptor substrate | Rattus norvegicus | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-benzyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-benzyl | requirement for the 4- and 6-hydroxyls of N-acetyl-galactosamine and the hydroxyl of galactose in the acceptor substrate | Sus scrofa | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-benzyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-o-nitrophenyl | - |
Homo sapiens | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-o-nitrophenyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-o-nitrophenyl | - |
Rattus norvegicus | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-o-nitrophenyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-o-nitrophenyl | - |
Sus scrofa | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-o-nitrophenyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-p-nitrophenyl | - |
Homo sapiens | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-p-nitrophenyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-p-nitrophenyl | - |
Rattus norvegicus | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-p-nitrophenyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-p-nitrophenyl | - |
Sus scrofa | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-p-nitrophenyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-phenyl | - |
Homo sapiens | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-phenyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-phenyl | - |
Rattus norvegicus | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-phenyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-phenyl | - |
Sus scrofa | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-phenyl | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-R | - |
Mus musculus | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-R | i.e. core class 2 | ? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-R | - |
Rattus norvegicus | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-R | i.e. core class 2 | ? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-R | - |
Sus scrofa | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-R | i.e. core class 2 | ? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-R | substrate specificity | Homo sapiens | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-R | i.e. core class 2 | ? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-R | involved in biosynthesis of O-glycans core class 2 | Mus musculus | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-R | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-R | involved in biosynthesis of O-glycans core class 2 | Homo sapiens | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-R | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-R | involved in biosynthesis of O-glycans core class 2 | Rattus norvegicus | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-R | - |
? | |
2.4.1.102 | UDP-N-acetyl-D-glucosamine + beta-D-galactosyl-1,3-N-acetyl-D-galactosaminyl-R | involved in biosynthesis of O-glycans core class 2 | Sus scrofa | UDP + beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl-R | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.4.1.102 | core 6-beta-GlcNAc-T | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
2.4.1.102 | 37 | - |
assay at | Homo sapiens |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.4.1.102 | 0.95 | - |
beta-D-galactosyl-1,3-(6-deoxy)-N-acetyl-D-galactosaminyl-benzyl | AML cells | Homo sapiens | |
2.4.1.102 | 1.5 | - |
beta-D-galactosyl-1,3-(6-deoxy)-N-acetyl-D-galactosaminyl-benzyl | colon | Homo sapiens | |
2.4.1.102 | 2 | - |
beta-D-galactosyl-1,3-(6-deoxy)-N-acetyl-D-galactosaminyl-benzyl | - |
Mus musculus | |
2.4.1.102 | 2.5 | - |
beta-D-galactosyl-1,3-(6-deoxy)-N-acetyl-D-galactosaminyl-benzyl | CML cells | Homo sapiens |